In a major development for India’s consumer goods and contract manufacturing sectors, Swara Baby Products has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise ₹1,000 crore through an initial public offering (IPO).
The diaper and hygiene products manufacturer—which is backed by Brainbees Solutions Ltd (the parent company of FirstCry)—is looking to leverage its position as India’s largest contract manufacturer of disposable hygiene products by value to expand its footprint.
1. The IPO Architecture & FirstCry’s Trimming Strategy
The ₹1,000 crore public issue is perfectly split between fresh growth capital and a partial exit route for early promoters and institutional anchors:
- Fresh Issue Component (₹500 Crore): Newly minted equity that will flow directly into the company’s treasury to bankroll its industrial expansion.
- Offer for Sale Component (OFS) (₹500 Crore): A pool of existing shares being divested by early backers, headlined by a ₹300 crore stake sale by FirstCry (Brainbees Solutions). FirstCry held a dominant 76.59% stake in Swara Baby at the time of filing.
- Promoter Offloading (₹200 Crore): The remaining slice of the OFS will see promoter entity Anadya Bon Merchari LLP offload up to ₹200 crore worth of equity.
- Subsidiary Status Intact: FirstCry’s board has explicitly stated that even after cashing out of the ₹300 crore chunk, Swara Baby will continue to remain a majority-controlled subsidiary of Brainbees Solutions.
[ SWARA BABY PRODUCTS ₹1,000 CR IPO SPLIT ]
[ Fresh Issue Pool ] ──────────────────► ₹500 Crore (Direct Company Growth Cash)
│
├──► MP Manufacturing Unit: ₹198.2 Crore
├──► Loan Repayments: ₹100 Crore
└──► Subsidiary Debt Clear: ₹27.5 Crore
[ Offer For Sale (OFS) Pool ] ─────────► ₹500 Crore (Existing Shareholder Liquidity)
│
├──► FirstCry (Brainbees): ₹300 Crore
└──► Anadya Bon Merchari: ₹200 Crore
2. Where the Fresh ₹500 Crore Capital Will Go
According to the regulatory draft papers, the company has mapped out precise corporate allocations for the fresh cash coming into the business:
- Greenfield Factory Setup (₹198.2 Crore): The largest chunk will fund the construction and machinery pipeline for a brand-new, high-speed manufacturing facility in Madhya Pradesh to augment its existing four production plants in Pithampur and Indore.
- Debt Reduction (₹100 Crore): Emarked strictly to pay off or prepay high-interest corporate borrowings to strengthen the company’s debt-to-equity ratio.
- Subsidiary Clean-up (₹27.5 Crore): Capital will be infused into its direct subsidiaries—Solis Hygiene, Swara Hygiene, and its newly acquired unit KAEHPL (K.A. Enterprises Hygiene Pvt Ltd)—to help completely wipe out their outstanding operational liabilities.
3. Financial Trajectory & B2B Moat
Founded in 2016, Swara Baby has established an incredibly sticky B2B contract manufacturing moat, commanding a massive 37% market share in baby diaper contract manufacturing and a 36% market share in adult diaper contract manufacturing across India during FY25.
While it operates its own localized consumer-facing brands (Cuddles and Shield), the bulk of its revenue comes from producing private-label lines for blue-chip consumer mainstays, including FirstCry itself, Piramal Pharma, and Himalaya Wellness Company.
| Financial Metric (FY ended March) | FY25 Reality | FY26 Performance | Year-on-Year Growth |
| Operating Revenue | ₹942.97 Crore | ₹1,163.90 Crore | +23.4% |
| Profit After Tax (PAT) | ₹80.67 Crore | ₹95.58 Crore | +18.5% |
| Dominant Product Driver | Baby Care Segment | 79% of total product sales | Resilient repeat-purchase profile |
Led by global book-running managers JM Financial and Avendus Capital, the public issue lands at a highly competitive intersection for the Indian consumer ecosystem. By packaging high double-digit revenue growth alongside steady, predictable bottom-line profits, Swara Baby is attempting to prove to the public markets that the backend infrastructure driving India’s baby care and adult incontinence boom is one of the most reliable utility plays in retail today.
